OpenAI introduces GPT-Rosalind, a biology-focused model for life-science workflows OpenAI is reportedly expanding beyond general-purpose assistants with GPT-Rosalind , a limited-access model tuned for life-science and biology workflows. Coverage from Ars Technica and VentureBeat des... Biotech AI Drug Discovery LLM OpenAI R&D Apr 17, 2026
AWS Launches Amazon Bio Discovery, Bringing Agentic AI Workflows to Drug Research Amazon Web Services has announced Amazon Bio Discovery , a new AI application aimed at accelerating life sciences research by connecting model-driven design with lab feedback loops. The promise is str... AI AWS Drug Discovery Healthcare Life Sciences Apr 14, 2026